Encorton
Sponsors
Sanofi-Aventis Recherche & Developpement, Medical University Of Warsaw
Conditions
Children primary nephropathy IgAMusculoskeletal diseasesMyocarditisinflammatory cardiomyopathy
Phase 3
SABINE - The efficacy and Safety of delayed-release Budesonide in children with primary IgA nephropathy - a multicenter, interventional phase III, randomized, placebo-controlled, double-blind study.
Not yet recruitingCTIS2024-518759-45-00
Target: 120Updated: 2025-11-25
A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of each of two dose levels of sarilumab in adults with early polymyalgia rheumatica
Not yet recruitingCTIS2024-511296-15-00
Target: 80Updated: 2026-06-16